2012年欧文発表

1. Ando T, Imamura H, Suzuki R, Aizaki H, Watanabe T, Wakita T, Suzuki T. Visualization and measurement of ATP levels in living cells replicating hepatitis C virus genome RNA. PLoS Pathog. 8(3): e1002561, 2012.
2. Arita M, Wakita T, Shimizu H. Valosin containing protein (VCP/p97) is required for poliovirus replication and involved in cellular protein secretion pathway in poliovirus infection. J Virol. 86(10): 5541-53, 2012.
3. Date T, Kato T, Kato J, Takahashi H, Morikawa K, Akazawa D, Murayama A, Tanaka-Kaneko K, Sata T, Tanaka Y, Mizokami M and Wakita T. Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone. J Virol. 86 (19): 10805-20, 2012.
4. Date T, Morikawa K, Tanaka Y, Tanaka-Kaneko K, Sata T, Mizokami M, Wakita T. Replication and infectivity of a novel genotype 1b hepatitis C virus clone. Microbiol Immunol. 56(5):308-17, 2012.
5. De W, Huanying Z, Hui L, Corina M, Xue G, Leng L, Hanri Z, Ling F, Yanling M, Huiqiong Z, Huan Z, Jing K, Caiyun L, Yoshida H, Changwen K. Phylogenetic and molecular characterization of Coxsackievirus A24 variant isolates from a 2010 acute hemorrhagic conjunctivitis outbreak in Guangdong, China. Virology J. 9: 41, 2012.
6. Fujii Y, Shimoike T, Takagi H, Murakami K, Todaka-Takai R, Park Y, Katayama K: Amplification of all 11 RNA segments of group A rotavirus based on reverse transcription polymerase chain reaction. Microbiol Immunol. 56:630-8, 2012.
7. Fujimoto T, Iizuka S, Enomoto M, Abe K, Yamashita K, Hanaoka N, Okabe N, Yoshida H, Yasui Y, Kobayashi M, Fujii Y, Tanaka H, Yamamoto M, Shimizu H: Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011. Emerg Infect Dis. 18: 337-339, 2012.
8. Fukazawa H, Suzuki T, Wakita T, Murakami Y. A cell-based, microplate colorimetric screen identifies 7,8-benzoflavone and green tea gallate catechins as inhibitors of the hepatitis C virus. Biol Pharm Bull. 35(8): 1320-7, 2012.
9. Hansman GS, DW. Taylor, JS. McLellan, TJ Smith, I Georgiev, JRH Tame, S-Y Park, M Yamazaki, F Gondaira, M Miki, K Katayama, K Murata, PD. Kwong. Structural Basis for Broad Detection of Genogroup II Noroviruses by a Monoclonal Antibody That Binds to a Site Occluded in the Viral Particle Journal of virology vol. 86, 3635-46, 2012.
10. Hansman GS, Shahzad-Ul-Hussan S, McLellan JS, Chuang GY, Georgiev I, Shimoike T, Katayama K, Bewley CA, Kwong PD. Structural basis for norovirus inhibition and fucose mimicry by citrate. J Virol. 86: 284-92, 2012.
11. Hansman GS, Taylor DW, McLellan JS, Smith TJ, Georgiev I, Tame JR, Park SY, Yamazaki M, Gondaira F, Miki M, Katayama K, Murata K, Kwong, PD. Structural basis for broad detection of genogroup II noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle. J Virol. 86(7): 3635-46, 2012.
12. Harada S, Oka T, Tokuoka E, Kiyota N, Nishimura K, Shimada Y, Ueno T, Ikezawa S, Wakita T, Wang Q, Saif LJ, Katayama K. A confirmation of sapovirusre-infection gastroenteritis cases with different genogroups and genetic shifts in the evolving sapovirus genotypes, 2002-2011. Arch Virol. 157(10): 1999-2003, 2012.
13. Ishii K, Kiyohara T, Yoshizaki S, Wakita T, Shimada T, Nakamura N, Nakashima K, Tada Y, Noda M. Epidemiological and genetic analyses of a diffuse outbreak of hepatitis A in Japan, 2010. J Clin Virol. 53, 219-24, 2012.
14. Ishii K, Li TC, Yoshizaki S, Shiota T, Kato T, Takeda N, Wakita T. Cloning of permissive and nonpermissive human hepatoma cell lines for hepatitis E virus infection. Hepato Inter. 6: 292, 2012.
15. Ishii K, Miyamura T, Kanda T, Tawada A, Sekimoto T, Wu S, Nakamoto S, Arai M, Fujiwara K, Imazeki F, Kiyohara T, Wakita T. Yokosuka O. Possible widespread presence of hepatitis A virus subgenotype IIIA in Japan: recent trend of hepatitis A causing acute liver failure. Hepatology Research. 42: 248-53, 2012.
16. Kamada K, Shoji I, Deng L, Aoki C, Ratnoglik SL, Wakita T, Hotta H. Generation of a recombinant reporter hepatitis C virus useful for the analyses of virus entry, intra-cellular replication and virion production. Microbes Infect. 14(1): 69-78, 2012.
17. Kanda T, Wu S, Kiyohara T, Nakamoto S, Jiang X, Miyamura T, Imazeki F, Ishii K, Wakita T, Yokosuka O. Interleukin-29 suppresses hepatitis A and C viral internal ribosomal entry site-mediated translation. Viral Immunol. 25(5): 379-86, 2012.
18. Kataoka C, Kaname Y, Taguwa S, Abe T, Fukuhara T, Tani H, Moriishi K, Matsuura Y. Baculovirus GP64-mediated entry into mammalian cells. J Virol. 86: 2610-20, 2012.
19. Kato K, Yazawa T, Taki K, Mori K, Wang S, Nishioka T, Hamaguchi T, Itoh T, Takenawa T, Kataoka C, Matsuura Y, Amano M, Murohara T, Kaibuchi K. The inositol 5-phosphatase SHIP2 is an effector of RhoA and is involved in cell polarity and migration. Mol Biol Cell. 23(13): 2593-604, 2012.
20. Khamrin P, Chaimongkol N, Malasao R, Suantai B, Saikhruang W, Kongsricharoern T, Ukarapol N, Okitsu S, Shimizu H, Hayakawa S, Ushijima H Maneekarn N. Detection and molecular characterization of cosavirus in adults with diarrhea, Thailand. Virus Genes. 44 (2): 244-6, 2012.
21. Khamrin P, Thongprachum A, Shimizu H, Okitsu S, Mizuguchi M, Hayakawa S, Maneekarn N Ushijima H. Detection of human bocavirus 1 and 2 from children with acute gastroenteritis in Japan. J Med Virol. 84 (6): 901-5, 2012.
22. Kitamoto N, Oka T, Katayama K, Li TC, Takeda N, Kato Y, Miyoshi T, Tanaka T. Novel monoclonal antibodies broadly reactive to human recombinant sapovirus-like particles. Microbiol Immunol. 56 (11): 760-770, 2012.
23. Kitaura K, Fujii Y, Matsutani T, Shirai K, Suzuki S, Takasaki T, Shimada S, Kametani Y, Shiina T, Takabayashi S, Katoh H, Ogasawara K, Kurane I, Suzuki R: A new method for quantitative analysis of the T cell receptor V region repertoires in healthy common marmosets by microplate hybridization assay. J Imm Method. 384:81-91, 2012.
24. Kobayashi F, Yamada S, Taguwa S, Kataoka C, Naito S, Hama Y, Tani H, Matsuura Y, Sugahara K. Specific interaction of the envelope glycoproteins E1 and E2 with liver herparan sulfate involved in the tissue tropismatic interaction by hepatitis C virus. Glycoconj J. 29(4): 211-20, 2012.
25. Koma T, Yoshimatsu K, Yasuda SP, Li TC, Amada T, Shimizu K, Isozumi R, Mai LT, Hoa NT, Nguyen V, Yamashiro T, Hasebe F, Arikawa J. A survey of rodent-borne pathogens carried by wild Rattus spp. in Northern Vietnam. Epidemiology and Infection. Epidemiol Infect. 1:1-9, 2012.
26. Kubota T, Kumagai A, Ito H, Furukawa S, Someya Y, Takeda N, Ishii K, Wakita T, Narimatsu H, Shirato H. Structural basis for the recognition of Lewis antigens by genogroup I norovirus. J Virol. 86(20): 11138-50, 2012.
27. Li TC, Ochiai S, Ishiko H, Wakita T, Miyamura T and Takeda N. A retrospective study on imported hepatitis E in Japan. Travel Med Infect Dis 10(2): 80-85, 2012.
28. Li Y, Yoshida H, Wang L, Tao Z, Wang H, Lin X, Xu A. An optimized method for elution of enteroviral RNA from a cellulose-based substrate. J Virol Methods. 186(1-2): 62-7, 2012.
29. Liu HM, Aizaki H, Machida K, Ou JH, Lai MM. Hepatitis C virus translation preferentially depends on active RNA replication. PLoS One. 7:e43600, 2012.
30. Matsuhira T, Kaji C, Murakami S, Maebashi K, Oka T, Takeda N, Katayama K. Evaluation of four antiseptics using a novel murine norovirus. Exp Anim. 61(1): 35-40, 2012.
31. Matsumura T, Kato T, Sugiyama N, Tasaka-Fujita M, Murayama A, Masaki T, Wakita T and Imawari M. 25-hydroxyvitamin D3 suppresses hepatitis C virus. Hepatology. 56 (4): 1231-9, 2012.
32. Miki M, Katayama K. In silico 3D structure analysis accelerates the solution of a real viral structure and antibodies docking mechanism. Frontiers in Microbiology 3: Article 387, 1-6, 2012.
33. Miyamoto S, Inoue H, Nakamura T, Yamada M, Sakamoto C, Urata Y, Okazaki T, Marumoto T, Takahashi A, Takayama K, Nakanishi Y, Shimizu H Tani K. Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma. Cancer Res. 72 (10): 2609-21, 2012.
34. Murayama A, Kato T, Akazawa D, Sugiyama N, Date T, Masaki T, Nakamoto S, Tanaka Y, Mizokami M, Yokosuka O, Nomoto A, Wakita T: Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1. J Virol. 86(4): 2143-2152, 2012.
35. Murayama A, Sugiyama N, Watashi K, Masaki T, Suzuki R, Aizaki H, Mizuochi T, Wakita T and Kato T. Japanese reference panel of blood specimens for evaluation of hepatitis C virus RNA and core antigen quantitative assays. J Clin Microbiol. 50 (6): 1943-9, 2012.
36. Murayama A, Sugiyama N, Yoshimura S, Ishihara-Sugano M, Masaki T, Kim S, Wakita T, Mishiro S and Kato T. A subclone of HuH-7 with enhanced intracellular hepatitis C virus production and evasion of virus related-cell cycle arrest. PLoS ONE. 7 (12): e52697, 2012.
37. Nakajima N, Kitamori Y, Ohnaka S, Mitoma Y, Mizuta K, Wakita T, Shimizu H, Arita M. Development of a Transcription-Reverse Transcription Concerted Reaction Method for Specific Detection of Human Enterovirus 71 from Clinical Specimens. J Clin Microbiol. 50(5): 1764-8, 2012.
38. Nakamura T, Ichinose H, Wariishi H. Flavin-containing monooxygenases from Phanerochaete chrysosporium responsible for fungal metabolism of phenolic compounds. Biodegradation. 23 (3): 343-50, 2012.
39. Nishimura Y, Shimizu H: Cellular receptors for human enterovirus species A. Front Microbiol. 3: 105, 2012.
40. Oka T, Mori K, Iritani N, Harada S, Ueki Y, Iizuka S, Mise K, Murakami K, Wakita T, Katayama K. Human sapovirus classification based on complete capsid nucleotide sequences. Arch Virol. 157(2): 349-52, 2012.
41. Saeed M, Gondeau C, Hmwe S, Yokokawa H, Date T, Suzuki T, Kato T, Maurel P and Wakita T. Replication of Hepatitis C Virus Genotype 3a in Cultured Cells. Gastroenterology. 144 (1): 56-8, 2012.
42. Sakaidani Y, Nomura T, Matsuura A, Ito M, Suzuki E, Murakami K, Nadano D, Matsuda T, Furukawa K, Okajima T: O-Linked-N-acetylglucosamine on extracellular protein domains mediates epithelial cell-matrix interactions. Nature Communications. 2: 583, 2012.
43. Sekiguchi S, Kimura K, Chiyo T, Ohtsuki T, Tobita Y, Tokunaga Y, Yasui F, Tsukiyama-Kohara K, Wakita T, Tanaka T, Miyasaka M, Mizuno K, Hayashi Y, Hishima T, Matsushima K, Kohara M. Immunization with a recombinant vaccinia virus that encodes nonstructural proteins of the hepatitis C virus suppresses viral protein levels in mouse liver. PLoS One. 7(12): e51656, 2012.
44. Sharp TM, SE Crawford, NJ Ajami, F Neill, RL Atmar, K Katayama, B Utama, MK Estes. Secretory pathway antagonism by calicivirus homologues of Norwalk virus nonstructural protein p22 is restricted to noroviruses. Virology Journal 9:181, 2012.
45. Shirato H. Norovirus recognition sites on histo-blood group antigens. Frontiers in Virology. 3:177, 2012.
46. Someya Y, Shirato H, Hasegawa K, Kumasaka T, Takeda N. Assembly of homogeneous norovirus-like particles accomplished by amino acid substitution. J Gen Virol. 92(10): 2320-2323, 2012.
47. Someya Y. From head to toe of the norovirus 3C-like protease. BioMol Concepts. 3(1): 41-56, 2012.
48. Suzuki R, Saito K, Kato T, Shirakura M, Akazawa D, Ishii K, Aizaki H, Kanegae Y, Matsuura Y, Saito I, Wakita T, Suzuki T. Trans-complemented hepatitis C virus particles as a versatile tool for study of virus assembly and infection. Virology. 432(1): 29-38, 2012.
49. Takeda M, Ikeda M, Ariumi Y, Wakita T, Kato N. Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines. J Gen Virol. 93(Pt 7):1422-31, 2012.
50. Tao Z, Song Y, Wang H, Zhang Y, Yoshida H, Ji S, Xu A, Song L, Liu Y, Cui N, Ji F, Li Y, Chen P, Xu W. Intercity Spread of Echovirus 6 in Shandong Province, China: Application of Environmental Surveillance in Tracing Circulating Enteroviruses. Appl Environ Microbiol. 78 (19): 6946-53, 2012.
51. Tominaga A, Kanda T, Akiike T, Komoda H, Ito K, Abe A, Aruga A, Kaneda S, Saito M, Kiyohara T, Wakita T, Ishii K, Yokosuka O, Sugiura N. Hepatitis A outbreak associated with a revolving sushi bar in Chiba, Japan: Application of molecular epidemiology. Hepatol Res. 42(8): 828-34, 2012.
52. Umeki S, Suzuki R, Ema Y, Shimojima M, Nishimura Y, Okuda M, Mizuno T. Anti-adhesive property of P-selectin glycoprotein ligand-1 (PSGL-1) due to steric hindrance effect. J Cell Biochem. 114 (6): 1271-85, 2012.
53. Weng L, Kohara M, Wakita T, Shimotohno K, Toyoda T. Detergent-induced activation of the hepatitis C virus genotype 1b RNA polymerase. Gene. 496(2): 79-87, 2012.
54. Weng L, Tian X, Gao Y, Watashi K, Shimotohno K, Wakita T, Kohara M, Toyoda T. Different mechanisms of hepatitis C virus RNA polymerase activation bycyclophilin A and B in vitro. Biochim Biophys Acta. 1820(12):1886-92, 2012.
55. Wong KT, Ng KY, Ong KC, Ng WF, Shankar SK, Mahadevan A, Radotra B, Su JI, Lau G, Ling AE, Chan KP, Macorelles P, Desai AS, Ravi V, Nagata N, Shimizu H, Takasaki T. Enterovirus 71 encephalomyelitis and Japanese encephalitis can be distinguished by topographic distribution of inflammation and specific intraneuronal detection of viral antigen and RNA in the central nervous system. Neuropathology and Applied Neurobiology. 38 (5): 443-53, 2012.
56. Yamamoto H, Suzuki J, Matsuda A, Ishida T, Ami Y, Suzaki Y, Adachi I, Wakita T, Takeda N, Li TC. Hepatitis E Outbreak in Monkey Facility, Japan. EID. 18 (12) 2032-4, 2012.
57. Yokoyama M, Oka T, Kojima H, Nagano T, Okabe T, Katayama K, Wakita T, Kanda T, Sato H. Structural basis for specific recognition of substrates by sapovirus protease. Frontiers in Microbiology. 3: Article 312, 1-10, 2012.

 2011年欧文発表

1. Akazawa D, Morikawa K, Omi N, Takahashi H, Nakamura N, Mochizuki H, Date T, Ishii K, Suzuki T and Wakita T. Production and Characterization of Hepatitis C Virus Particles from Serum-free Culture. Vaccine. 29: 4821-4828, 2011.
2. Aly HH, Oshiumi H, Shime H, Matsumoto M, Wakita T, Shimotohno K, Seya T. Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV). PLoS One. 6(6): e21284, 2011.
3. Arita M, Iwai M, Wakita T, Shimizu H. Development of poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum. Clin Vaccine Immunol. 18: 1889-1894, 2011.
4. Arita M, Kojima H, Nagano T, Okabe T, Wakita T, Shimizu H. Phosphatidylinositol-4 kinase III beta is a target of enviroxime-like compounds for anti-poliovirus activity. J Virol. 85 (5): 2364-2372. 2011.
5. Arita M, Masujima S, Wakita T, Shimizu H. Particle Agglutination Method for Poliovirus Identification. J Vis Exp. 50, doi: 10.3791/2824, 2011.
6. Ariumi Y, Kuroki M, Maki M, Ikeda M, Dansako H, Wakita T, Kato N. The ESCRT system is required for hepatitis C virus production. PLoS One. 11;6(1): e14517, 2011.
7. Arnaud N, Dabo S, Akazawa D, Fukasawa M, Shinkai-Ouchi F, Hugon J, Wakita T, Meurs EF. Hepatitis C virus reveals a novel early control in acute immune response. PLoS Pathog. 7(10): e1002289, 2011.
8. Bull RA, Hyde J, Mackenzie JM, Hansman GS, Oka T, Takeda N, White PA. Comparison of the replication properties of murine and human calicivirus RNA-dependent RNA polymerases. Virus Genes. 42: 16-27, 2011.
9. Fujii Y, Hayasaka D, Kitaura K, Takasaki T, Suzuki R, Kurane I. T cell clones expressing different T cell receptors accumulate in the brains of dying and surviving mice following peripheral infection with Far Eastern strain of tick-borne encephalitis virus. Viral Immunology. 24:291-302, 2011.
10. Hikosaka K, Noritake H, Kimura W, Sultana N, Sharkar MT, Tagawa Y, Uezato T, Kobayashi Y, Wakita T, Miura N. Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry. Biomed Res. 32(2): 143-50, 2011.
11. Himeda T, Hosomi T, Asif N, Shimizu H, Okuwa T, Muraki Y, Ohara Y: The preparation of an infectious full-length cDNA clone of Saffold virus. Virol J. 8: 110, 2011.
12. Honda M, Takehana K, Sakai A, Tagata Y, Shirasaki T, Nishitani S, Muramatsu T, Yamashita T, Nakamoto Y, Mizukoshi E, Sakai Y, Yamashita T, Nakamura M, Shimakami T, Yi M, Lemon SM, Suzuki T, Wakita T, Kaneko S. Hokuriku Liver Study Group. Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C. Gastroenterology. 141(1): 128-40,140.e1-2, 2011.
13. Ikeda M, Kawai Y, Mori K, Yano M, Abe K, Nishimura G, Dansako H, Ariumi Y, Wakita T, Yamamoto K, Kato N. Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C. Liver Int. 31(6): 871-80, 2011.
14. Inoue Y, Aizaki H, Hara H, Matsuda M, Ando T, Shimoji T, Murakami K, Masaki T, Shoji I, Homma S, Matsuura Y, Miyamura T, Wakita T, Suzuki T. Chaperonin TRiC/CCT participates in replication of hepatitis C virus genome via interaction with the viral NS5B protein. Virology. 410: 38-47, 2011.
15. Ishii K, Kiyohara T, Yoshizaki S, Shimada T, Nakamura N, Tada Y, Noda M, Wakita T. Epidemiological and genetic analysis of a diffuse outbreak of hepatitis A in Japan, 2010. Hepato Inter. 5: 204-205, 2011.
16. Iwai M, Horimoto E, Obara M, Obuchi M, Kurata T, Kawagoshi K, Nakamura S, Shimizu H, Yoshida H, Takizawa T: Endemic transmission of echovirus 30 in Toyama, Japan in 2010 is verified by environmental surveillance. Jpn J Infect Dis. 64: 165-167, 2011.
17. Iwasaki Y, Mori K, Ishii K, Maki N, Iijima S, Yoshida T, Okabayashi S, Katakai Y, Lee YJ, Saito A, Funai H, Kimura N, Ageyama N, Yoshizaki S, Suzuki T, Yasutomi Y, Miyamura T, Kannnagi M, Akari H. Long-term persistent GBV-B infection and development of a chronic and progressive hepatitis C-like disease in marmosets. Front Microbiol. 2: 240, 2011.
18. Jiang H, Weng L, Zhang N, Arita M, Li R, Chen L, Toyoda T. Biochemical characterization of enterovirus 71 3D RNA polymerase. Biochim Biophys Acta. 1809: 211-219, 2011.
19. Kitajima M, Oka T, Haramoto E, Phanuwan C, Takeda N, Katayama K, Katayama H. Genetic Diversity of Genogroup IV Noroviruses in Wastewater in Japan. Letters in Applied Microbiology. 52(2): 181-184, 2011.
20. Kitaura K, Fujii Y, Hayasaka D, Matsutani T, Shirai K, Nagata N, Lim CK, Suzuki S, Takasaki T, Suzuki R, Kurane I. High clonality of virus-specific T lymphocytes defined by T cell receptor usage in the brains of mice infected with West Nile virus. J Immunol. 187: 3919-30, 2011.
21. Konno M, Yoshioka M, Sugie M, Maguchi T, Nakamura T, Kizawa M, Umegaki Y, Yasutake H, Ishikawa Y, Hanaoka N, Okabe N, Taniguchi T, Shimizu H, Fujimoto T: Fourteen years' surveillance of coxsackievirus group A in Kyoto 1996?2009 using mouse, RD-18S, and Vero Cells. Jpn J Infect Dis. 64: 167-168, 2011.
22. Li TC, Song S, Yang Q, Ishii K, Takeda N, Wakita T. A cell culture system for hepatitis E virus. Hepato Inter. 5: 202, 2011.
23. Li TC, Yoshimatsu K, Yasuda SP, Arikawa J, Koma T, Kataoka M, Ami Y, Suzaki Y, Mai LT, Hoa NT, Yamashiro T, Hasebe F, Takeda N, Wakita T. Characterization of self-assembled virus-like particles of rat hepatitis E virus generated by recombinant baculoviruses. J Gen Virol. 92: 2830-2837, 2011.
24. Matsutani T, Fujii Y, Kitaura K, Suzuki S, Tsuruta Y, Takasaki T, Ogasawara K, Nishimoto N, Kurane I, Suzuki R. Increased positive selection pressure within the complementarity determining regions of the T-cell receptor beta gene in New World monkeys. Am J Primatol. 73: 1082-1092, 2011.
25. Miyamura K, Nishimura Y, Abo M, Wakita T, Shimizu H: Adaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1. J Gen Virol. 92(2): 287-291, 2011.
26. Mori K, Ikeda M, Ariumi Y, Dansako H, Wakita T, Kato N. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system. Virus Res. 157(1): 61-70, 2011.
27. Morohashi K, Sahara H, Watashi K, Iwabata K, Sunoki T, Kuramochi K, Takakusagi K, Miyashita H, Sato N, Tanabe A, Shimotohno K, Kobayashi S, Sakaguchi K, Sugawara F. Cyclosporin A associated helicase-like protein facilitates the association of hepatitis C virus RNA polymerase with its cellular cyclophilin B. PLoS One. 6: e18285, 2011.
28. Oka T, Murakami K, Wakita T, Katayama K.Comparative site-directed mutagenesis in the catalytic amino acid triad in calicivirus proteases. Microbiology and Immunology. 55(2): 108-114, 2011.
29. Oka T, Takagi H, Tohya Y, Murakami K, Takeda N, Wakita T, Katayama K. Bioluminescence technologies to detect calicivirus protease activity in cell-free system and in infected cells. Antiviral Research. 90(1): 9-16, 2011.
30. Okamoto Y, Masaki T, Murayama A, Munakata T, Nomoto A, Nakamoto S, Yokosuka O, Watanabe H, Wakita T, Kato T. Development of recombinant hepatitis C virus with NS5A from strains of genotypes 1 and 2. Biochem Biophys Res Commun. 410: 404-409, 2011.
31. Pham NTK, Takanashi S, Tran DN, Abeysekera C, Abeygunawardene A, Khamrin P, Okitsu S, Shimizu H, Mizuguchi M, Ushijima H. Human parechovirus infection in children hospitalized with acute gastroenteritis in Sri Lanka. J Clin Microbiol. 49(1): 364-366, 2011.
32. Saeed M, Shiina M, Date T, Akazawa D, Watanabe N, Murayama A, Suzuki T, Watanabe H, Hiraga N, Imamura M, Chayama K, Choi Y, Krawczynski K, Liang TJ, Wakita T, Kato T. In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosis. Hepatology. 54: 425-433, 2011.
33. Saeed M, Suzuki R, Watanabe N, Masaki T, Tomonaga M, Muhammad A, Kato T, Matsuura Y, Watanabe H, Wakita T, Suzuki T. Role of the endoplasmic reticulum-associated degradation (ERAD) pathway in degradation of hepatitis C virus envelope proteins and production of virus particles. J Biol Chem. 286: 37264-37273, 2011.
34. Salim MT, Aoyama H, Sugita K, Watashi K, Wakita T, Hamasaki T, Okamoto M, Urata Y, Hashimoto Y, Baba M. Potent and selective inhibition of hepatitis C virus replication by novel phenanthridinone derivatives. Biochem Biophys Res Commun. 415: 714-719, 2011.
35. Sasaki J, Ishikawa K, Arita M, Taniguchi K. ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J. 31: 754-766, 2011.
36. Shirato H. Norovirus and Histo-blood Group Antigens. Japanese Journal of Infectious Diseases. 64: 95-103, 2011.
37. Someya Y, Takeda N. Functional Consequences of Mutational Analysis of Norovirus Protease. FEBS Lett. 585(2): 369-374, 2011.
38. Sugiyama M, Tanaka Y, Wakita T, Nakanishi M, Mizokami M. Genetic Variation of the IL-28B Promoter Affecting Gene Expression. PLoS One. 6(10): e26620, Epub Oct25, 2011.
39. Sun LM, Zheng HY, Zheng HZ, Guo X, He JF, Guan DW, Kang M, Liu Z, Ke CW, Li JS, Liu L, Guo RN, Yoshida H, Lin JY. An enterovirus 71 epidemic in guangdong province of china, 2008: epidemiological, clinical, and virogenic manifestations. Jpn J Infect Dis. 64 (1): 13-18, 2011.
40. Tamura R, Kanda T, Imazeki F, Wu S, Nakamoto S, Tanaka T, Arai M, Fujiwara K, Saito K, Roger T, Wakita T, Shirasawa H, Yokosuka O. Hepatitis C Virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of Toll-like receptor 4. J Infect Dis. 204(5): 793-801, 2011.
41. Wakita T, Suzuki T, Evans MJ, Shimotohno K, Chayama K, Matsuura Y, Hijikata M, Moriishi K, Seya T, Enomoto N, Koike K, Kato N, Kanto T, Hotta H. Will there be an HCV meeting in 2020? Summary of the 17th international meeting on hepatitis C virus and related viruses. Gastroenterology. 141(1): e1-5, 2011.
42. Watanabe N, Aizaki H, Matsuura T, Kojima S, Wakita T, Suzuki T : Hepatitis C virus RNA replication in human stellate cells regulates gene expression of extracellular matrix-related molecules. Biochem Biophys Res Commun. 407: 135-40, 2011.
43. Winkelmann ER, Widman DG, Suzuki R, Mason PW. Analyses of mutations selected by passaging a chimeric flavivirus identify mutations that alter infectivity and reveal an interaction between the structural proteins and the nonstructural glycoprotein NS1. Virology. 421: 96-104, 2011.
44. Xing L, Wang J.C, Li T.C., Yasutomi Y, Lara J, Khudyakov Y, Schofield D, Emerson S.U, Purcell R.H, Takeda N, Miyamura T, Cheng R.H. Spatial configuration of hepatitis E virus antigenic domain. Journal of Virology. 85: 1117-1124, 2011.
45. Yamamoto M, Aizaki H, Fukasawa M, Teraoka T, Miyamura T, Wakita T, Suzuki T. The structural requirements of virion-associated cholesterol for infectivity, buoyant density and apolipoprotein association of hepatitis C virus. J Gen Virol. 92: 2082-7, 2011.
46. Yamamoto M, Sakamoto N, Nakamura T, Itsui Y, Nakagawa M, Nishimura-Sakurai Y, Kakinuma S, Azuma S, Tsuchiya K, Kato T, Wakita T, Watanabe M. Studies on virus kinetics using infectious fluorescence-tagged hepatitis C virus cell culture. Hepatol Res. 41: 258-69, 2011.
47. Yoshida T, Miyasaka T, Azegami Y, Uchiyama Y, Kasahara H, Ueda H, Nagase H, Fujita S, Ishii K, Noda M. Investigation of epidemiology and HAV genomes regarding three hepatitis A infections that occurred in April-May, 2010-Nagano. Jpn J Infect Dis. 64:260-261, 2011.

2010年欧文発表

1. Arita M, Masujima S, Wakita T, Shimizu H. Development of a particle agglutination method with soluble virus receptor for identification of poliovirus. J Clin Microbiol. 48(8): 2698-2702, 2010.
2. Arita M, Takebe Y, Wakita T, Shimizu H. A bifunctional anti-enterovirus compound that inhibits replication and early stage of enterovirus 71 infection. J Gen Virol. 91 (11): 2734-44, 2010.
3. Arnaud N, Dabo S, Maillard P, Budkowska A, Kalliampakou KI, Mavromara P, Garcin D, Hugon J, Gatignol A, Akazawa D, Wakita T, Meurs EF. Hepatitis C virus controls interferon production through PKR activation. PLoS One. 5(5): e10575, 2010.
4. Banaudha K, Orenstein JM, Korolnek T, St Laurent GC 3rd, Wakita T, Kumar A.Primary hepatocyte culture supports hepatitis C virus replication: a model for infection-associated hepatocarcinogenesis. Hepatology. 51(6): 1922-32, 2010.
5. Hishiki T, Shimizu Y, Tobita R, Sugiyama K, Ogawa K, Funami K, Ohsaki Y, Fujimoto T, Takaku H, Wakita T, Baumert TF, Miyanari Y, Shimotohno K. Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. J Virol. 84(22): 12048-57, 2010.
6. Hmwe SS, Aizaki H, Date T, Murakami K, Ishii K, Miyamura T, Koike K, Wakita T, Suzuki T. Identification of hepatitis C virus genotype 2a replicon variants with reduced susceptibility to ribavirin. Antiviral Res. 85: 520-524, 2010.
7. Iizuka S, Oka T, Tabara K, Omura T, Katayama K, Takeda N, Noda M. Detection of sapoviruses and noroviruses in an outbreak of gastroenteritis linked genetically to shellfish. Journal of Medical Virology. 82(7): 1247-1254, 2010.
8. Kitajima M, Oka T, Haramoto E, Katayama H, Takeda N, Katayama K, Ohgaki S. Detection and genetic analysis of human sapoviruses in river water in Japan. Applied and Environmental Microbiology. 76(8): 2461-2467, 2010.
9. Kitajima M, Oka T, Haramoto E, Takeda N, Katayama K, Katayama H. Seasonal distribution and genetic diversity of genogroups I, II, and IV noroviruses in the Tamagawa River, Japan. Environmental Science & Technology. 44(18): 7116-22, 2010.
10. Kitajima M, Oka T, Takagi H, Tohya Y, Katayama H, Takeda N, Katayama K. Development and application of a broadly reactive real-time reverse transcription-PCR assay for detection of murine noroviruses. Journal of Virological Methods. 169(2): 269-273, 2010.
11. Kushima Y, Wakita T, Hijikata M. A disulfide-bonded dimer of the core protein of hepatitis C virus is important for virus-like particle production. J Virol. 84(18):9118-27, 2010.
12. Li T.C., Xing L., Mayazaki N., Simon M.N., Wall J.S., Moore M., Wang C.Y., Takeda N., Wakita T., Miyamura T., Cheng R.H. Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. Journal of Biological Chemistry. 285: 33175-33183, 2010.
13. Masaki T, Suzuki R, Saeed M, Mori K, Matsuda M, Aizaki H, Ishii K, Maki N, Miyamura T, Matsuura Y, Wakita T, Suzuki T. Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription. J Virol. 84: 5824-5835, 2010.
14. Mishima K, Sakamoto N, Sekine-Osajima Y, Nakagawa M, Itsui Y, Azuma S, Kakinuma S, Kiyohashi K, Kitazume A, Tsuchiya K, Imamura M, Hiraga N, Chayama K, Wakita T, Watanabe M. Cell culture and in vivo analyses of cytopathic hepatitis C virus mutants. Virology. 405(2): 361-369, 2010.
15. Miyoshi M, Yoshizumi S, Jinushi M, Ishida S, Okui T, Okano M, Shouji M, Tanaka S, Saigusa J, Mori A, Tanabe H, Yamaguchi R, Nishimura Y, Shimizu H. A case of paralytic poliomyelitis associated with poliovirus vaccine strains in Hokkaido, Japan. Jpn J Infect Dis. 63(3): 216-217, 2010.
16. Moriishi K, Shoji I, Mori Y, Suzuki R, Suzuki T, Kataoka C, Matsuura Y. Involvement of PA28gamma in the propagation of hepatitis C virus. Hepatology. 52: 411-420, 2010.
17. Motomura K, Yokoyama M, Ode H, Nakamura H, Mori H, Kanda T, Oka T, Katayama K, Noda M, Tanaka T, Takeda N, Sato H, and the Norovirus Surveillance Group of Japan. Divergent Evolution of Norovirus GII/4 by Genome Recombination over 2006-2009 in Japan. Journal of Virology. 84(16): 8085-8097, 2010.
18. Murayama A, Weng L, Date T, Akazawa D, Tian X, Suzuki T, Kato T, Tanaka Y, Mizokami M,Wakita T, Toyoda T: RNA Polymerase Activity and Specific RNA Structure are Required for Efficient HCV Replication in Cultured Cells. PLoS Pathog. 6(4): e1000885, 2010.
19. Nishimura K, Wakita T, Shimizu H. Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog. 6(11): e1001174, 2010.
20. Podevin P, Carpentier A, Pene V, Aoudjehane L, Carriere M, Zaidi S, Hernandez C, Calle V, Meritet JF, Scatton O, Dreux M, Cosset FL, Wakita T, Bartenschlager R, Demignot S, Conti F, Rosenberg AR, Calmus Y. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. Gastroenterology. 139(4): 1355-64, 2010.
21. Sharp, T. M., Guix, S., Katayama K., Crawford, S. E., Estes, M. K. Inhibition of Cellular Protein Secretion by Norwalk Virus Nonstructural Protein p22 Requires a Mimic of an Endoplasmic Reticulum Export Signal. PLoS ONE. 5(10) e13130, 2010.
22. Shirasaki T, Honda M, Mizuno H, Shimakami T, Okada H, Sakai Y, Murakami S, Wakita T, Kaneko S. La protein required for internal ribosome entry site-directed translation is a potential therapeutic target for hepatitis C virus replication. J Infect Dis. 202(1): 75-85, 2010.
23. Takahashi H, Akazawa D, Kato T, Date T, Shirakura M, Nakamura N, Mochizuki H, Tanaka-Kaneko K, Sata T, Tanaka Y, Mizokami M, Suzuki T, Wakita T. Biological properties of purified recombinant HCV particles with an epitope-tagged envelope. Biochem Biophys Res Commun. 395: 565-71, 2010.
24. Ueki Y, Shoji M, Okimura Y, Miyota Y, Masago Y, Oka T, Katayama K, Takeda N, Noda M, Miura T, Sano D, Omura T. Detection of sapovirus in oysters. Microbiology and Immunology. 54(8): 483-486, 2010.
25. von dem Bussche A, Machida R, Li K, Loevinsohn G, Khander A, Wang J, Wakita T, Wands JR, Li J. Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication. J Hepatol. 53(5): 797-804, 2010.
26. Watashi K, Yeung ML, Starost MF, Hosmane RS, Jeang KT. Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J Biol Chem. 285(32): 24707-24716, 2010.
27. Watashi K. Alisporivir, a cyclosporin derivative that selectively inhibits cyclophilin, for the treatment of HCV infection. Curr Opin Investig Drugs. 11(2): 213-224, 2010.
28. Weng L, Hirata Y, Arai M, Kohara M, Wakita T, Watashi K, Shimotohno K, He Y, Zhong J, Toyoda T. Sphingomyelin activates hepatitis C virus RNA polymerase in a genotype-specific manner. J Virol. 84(22): 11761-11770, 2010.
29. Yamashita Y, Ootsuka Y, Kondo R, Oseto M, Doi M, Miyamoto T, Ueda T, Kondo H, Tanaka T, Wakita T, Katayama K, Takeda N, Oka T. Molecular characterization of Sapovirus detected in a gastroenteritis outbreak at a wedding hall. Journal of Medical Virology. 82(4): 720-726, 2010.
30. Yang L, Kiyohara T, Kanda T, Imazeki F, Fujiwara K, Gauss-Muller V, Ishii K, Wakita T, Yokosuka O. Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha. Virology Journal. 7: 212, 2010.
31. Zhang YY, Zhang BH, Ishii K, Liang TJ. A novel function of CD81 in controlling hepatitis C virus replication. Journal of Virology. 84: 3396-3407, 2010.